The pharmaceutical landscape for blood sugar is evolving, and transdermal GLP-1 delivery systems represent a potential breakthrough. Unlike subcutaneous injections, this method offers a simpler way to administer GLP-1 medications. These transdermal systems gradually release the medication through the skin offering a even dose of the active agent… Read More